Similar articles

• Beta-adrenergic blocking drugs in the management of hypertension.

  Bergman SM, Wallin JD. Bergman SM, et al. Compr Ther. 1987 Nov;13(11):58-62. Compr Ther. 1987. PMID: 2890462 No abstract available.
• [Symptoms and cardiovascular complications of the withdrawal of beta-blocker treatment. Practical implications].

  Plouin PF. Plouin PF. Therapie. 1984 Jul-Aug;39(4):379-90. Therapie. 1984. PMID: 6148791 Review. French. No abstract available.
• [Adrenergic beta receptor blockaders in the treatment of arterial hypertension].

  Chodakowska J. Chodakowska J. Pol Tyg Lek. 1982 Nov 15;37(44):1331-4. Pol Tyg Lek. 1982. PMID: 6131408 Polish. No abstract available.
• Beta adrenoceptor blocking drugs in hypertension.

  Turner P. Turner P. Clin Invest Med. 1978;1(3-4):129-33. Clin Invest Med. 1978. PMID: 42502 Review. No abstract available.
• Mechanisms of action and the clinical pharmacology of beta-adrenergic blocking drugs.

  Lowenthal DT, Saris SD, Packer J, Haratz A, Conry K. Lowenthal DT, et al. Am J Med. 1984 Oct 5;77(4A):119-27. doi: 10.1016/s0002-9343(84)80047-9. Am J Med. 1984. PMID: 6148890 Review.